We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+15.27%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.3B
AUM Growth
+$1.38B
Cap. Flow
-$440M
Cap. Flow %
-2.54%
Top 10 Hldgs %
32.07%
Holding
728
New
61
Increased
216
Reduced
343
Closed
55

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$85M
2
ABT icon
Abbott
ABT
+$53.8M
3
EXC icon
Exelon
EXC
+$46.6M
4
BSX icon
Boston Scientific
BSX
+$42.6M
5
ABBV icon
AbbVie
ABBV
+$32.4M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$80.5M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$54.5M
3
CRWD icon
CrowdStrike
CRWD
+$45.7M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$40.6M
5
MRK icon
Merck
MRK
+$39.3M

Sector Composition

Rank Sector Weight
1 Technology 36.26%
2 Healthcare 22.78%
3 Financials 10.33%
4 Consumer Discretionary 7.75%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTC icon
76
PTC
PTC
$13.7B
$55.4M 0.32%
321,208
-53,770
-14% -$8.66M
PFE icon
77
Pfizer
PFE
$140B
$54.3M 0.31%
2,240,955
+581,355
+35% +$13.6M
AWK icon
78
American Water Works
AWK
$26.3B
$53.9M 0.31%
387,482
+1,617
+0.4% +$232K
COST icon
79
Costco
COST
$415B
$52.3M 0.3%
52,866
-3,487
-6% -$3.47M
EXC icon
80
Exelon
EXC
$48.6B
$52.3M 0.3%
1,203,699
+1,047,459
+670% +$46.6M
AMAT icon
81
Applied Materials
AMAT
$426B
$51.5M 0.3%
281,482
-68,359
-20% -$10.8M
EBAY icon
82
eBay
EBAY
$48.6B
$50.7M 0.29%
680,847
-115,988
-15% -$8.22M
KO icon
83
Coca-Cola
KO
$354B
$50M 0.29%
706,293
+207,955
+42% +$14.8M
ZS icon
84
Zscaler
ZS
$23B
$49.7M 0.29%
158,310
+13,217
+9% +$3.29M
DIS icon
85
Walt Disney
DIS
$165B
$48.9M 0.28%
394,172
+70,392
+22% +$7.31M
DGX icon
86
Quest Diagnostics
DGX
$25.1B
$47.7M 0.28%
265,771
-12,885
-5% -$2.24M
BMY icon
87
Bristol-Myers Squibb
BMY
$127B
$46.4M 0.27%
1,002,904
-92,461
-8% -$4.54M
SNPS icon
88
Synopsys
SNPS
$71.5B
$45.8M 0.26%
89,418
+13,051
+17% +$6.08M
JNJ icon
89
Johnson & Johnson
JNJ
$635B
$45.2M 0.26%
295,670
-3,444
-1% -$529K
SYF icon
90
Synchrony
SYF
$23.7B
$44.4M 0.26%
665,006
+72,128
+12% +$4.03M
INSM icon
91
Insmed
INSM
$23.2B
$44.2M 0.25%
438,688
-16,720
-4% -$1.28M
IDXX icon
92
Idexx Laboratories
IDXX
$42.9B
$42.4M 0.24%
79,028
-3,163
-4% -$1.51M
ADI icon
93
Analog Devices
ADI
$181B
$42.3M 0.24%
177,580
+73,385
+70% +$15.3M
PEP icon
94
PepsiCo
PEP
$186B
$41.5M 0.24%
314,457
-67,448
-18% -$9.09M
PH icon
95
Parker-Hannifin
PH
$125B
$41.1M 0.24%
58,911
-790
-1% -$499K
CRDO icon
96
Credo Technology Group
CRDO
$39.7B
$38.8M 0.22%
418,771
-309,754
-43% -$18.1M
CRWD icon
97
CrowdStrike
CRWD
$187B
$38M 0.22%
298,632
-421,536
-59% -$45.7M
NBIX icon
98
Neurocrine Biosciences
NBIX
$17.7B
$37.5M 0.22%
298,551
-32,289
-10% -$3.7M
FISV
99
Fiserv Inc
FISV
$27.2B
$37.1M 0.21%
215,437
+4,231
+2% +$767K
CME icon
100
CME Group
CME
$92.2B
$36.5M 0.21%
132,581
+49,537
+60% +$13.5M

Similar funds

Candriam SCA's Q2 2025 Portfolio in Review

As of Q2 2025, Candriam SCA held 728 positions worth $17.3B, up 8.6% from $16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q2 2025 filing shows 61 new, 216 increased, 343 reduced and 55 closed positions. Its largest new stake was Tapestry: 260,834 shares worth $22.9M. The largest sale was Tesla, an estimated $80.5M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2025 buy was Tapestry: 260,834 shares worth $22.9M.
  • Candriam SCA added most to Broadcom in Q2 2025, an estimated $85M increase.
  • Candriam SCA's biggest Q2 2025 reduction was Tesla, cutting an estimated $80.5M.
  • Candriam SCA fully exited Banco Macro in Q2 2025, selling an estimated $17.6M.
  • Candriam SCA's ten largest holdings make up 32% of its $17.3B portfolio in Q2 2025.
  • Candriam SCA opened 61 new positions and closed 55 in Q2 2025.
  • Candriam SCA's portfolio value rose 8.6% quarter-over-quarter to $17.3B.

Based on Candriam SCA's 13F filing for Q2 2025, filed 8 Aug 2025.